3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
7
Small Cell Lung Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Rectal Neoplasms
1
Pancreatic Adenocarcinoma
1
PD-L1-selected Solid Tumors
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Follicular
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Unresectable or Metastatic Solid Malignancy
1
Advanced Liver Cancers
1
Interventions
Tiragolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
PD-L1-selected Solid Tumors
×
Tiragolumab
×
Clear all
NCT05661578
2026-02-09
SKYSCRAPER-11
Hoffmann-La Roche
Phase 2
Completed
64 enrolled